Trial Profile
The modulation of neural circuity by Atomoxetine in healthy male volunteers during fMRI
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacodynamics
- 29 Dec 2008 New trial record.